News Alert: $BCTX announces a key collaboration with Memorial Sloan Kettering’s Therapeutics to advance its next-gen immunotherapy Bria-OTS+™, starting with breast cancer. A major step forward powered by MSK’s clinical expertise.
https://globenewswire.com/news-release/2025/1...ancer.html